Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-16T18:41:42.759Z Has data issue: false hasContentIssue false

Effectiveness of Paliperidone Depot in Seriously Violent Men With Comorbid Schizophrenia and Dissocial Personality Disorder in a Uk High-Security Hospital

Published online by Cambridge University Press:  23 March 2020

A.M. Mortlock*
Affiliation:
West London Mental Health NHS Trust, Broadmoor Hospital, Berkshire, United Kingdom
F. Larkin
Affiliation:
West London Mental Health NHS Trust, Broadmoor Hospital, Berkshire, United Kingdom
C. Ross
Affiliation:
West London Mental Health NHS Trust, Broadmoor Hospital, Berkshire, United Kingdom
S. Sengupta
Affiliation:
West London Mental Health NHS Trust, Broadmoor Hospital, Berkshire, United Kingdom
M. Das
Affiliation:
West London Mental Health NHS Trust, Broadmoor Hospital, Berkshire, United Kingdom
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

High-security hospital patients are often complex in presentation characterised by treatment resistance, medication non-concordance and history of violence. Paliperidone is licensed as both an oral and depot antipsychotic for the treatment of schizophrenia. Whilst there is data for the effectiveness of paliperidone palmitate (PP), there are no studies involving patients in forensic settings or those with comorbid personality disorder.

Objective

To determine the effects of PP on violence, aggression and personality pathology.

Aim

To evaluate the clinical effectiveness of PP.

Methods

This was a retrospective service evaluation involving 11 patients. Medical records and interviews with the treating psychiatrist were used to formulate clinical global impression (CGI) and to identify incidents of violence. The effect on personality symptom domains; cognitive-perceptual, impulsive-behavioural dyscontrol and affective dysregulation was ascertained, as well as engagement with occupational and psychological therapies.

Results

Six patients were being prescribed PP. All 6 showed improvement in the CGI score with benefits in the symptom domains. Two patients demonstrated a reduction in violence risk and 2 remained incident-free. There was improvement in engagement with therapies. Benefits were also seen in aspects of personality for those who had discontinued PP.

Conclusions

This pragmatic study of a small but complex patient group demonstrated that PP was effective in reducing symptoms of schizophrenia. Additionally and for the first time, it was shown that PP was also effective in reducing violence as well as improving personality pathology dimensions in a comorbid patient. This could have significant implications for management of high-security patients.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV695
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.